Concerns over the vaccine scepticism of the new US Department of Health and Human Services (HHS) Secretary are only increasing as Robert F Kennedy Jr (RFK Jr) settles in to his new role.

Berlin, Germany-based radioisotopes specialist Eckert & Ziegler today announced a comprehensive strategic partnership with ...

Rare disease-focused biopharma Zevra Therapeutics has agreed to sell its Rare Pediatric Disease Priority Review Voucher (PRV) to an undisclosed buyer for $150 million.

The government of Ukraine plans to increase public procurements of drugs this year and to make them more affordable for local ...

Privately-held French drugmaker Servier has announced the appointment of Nitza Thomasson as executive director, R&D Neurology ...

Boston, USA-based biotech Sionna Therapeutics has recently raised $191 million through its initial public offering (IPO), marking a step forward in its efforts to develop treatments for cystic ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Gamifant (emapalumab-Izsg), submitted by Swedish Orphan Biovitrum, the Nordic biotech also ...

The Californian company earlier announced the US Food and Drug Administration’s (FDA) acceptance of a supplemental New Drug ...

UCB exceeded market expectations in the fourth quarter of 2024, reporting revenue of 1.89 billion euros ($2.05 billion), an 8 ...

Johnson & Johnson (NYSE: JNJ) has taken legal action against Samsung Bioepis, accusing the South Korean biotech of violating ...

A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...

HBM Alpha Therapeutics has signed a collaboration and licensing agreement, granting an unnamed business partner exclusive ...